Loading…
INVO Fertility, Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in IVF.
▼ -100.0% over 5Y.
today you would have $0.01▼ -100.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $3.77 | $1,166.40 | $1,944.00 | $12,211.20 | |
| P/S | 0.8x | 0.3x | 0.6x | 1.1x | 6.3x |
| P/B | 0.3x | 0.2x | 0.3x | 3.8x | — |
| EPS | -$214.64 | -$3,782.65 | -$4,644.28 | -$25,811.64 | |
| Profit margin | -303.46% | -340.92% |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ONCOOnconetix, Inc. | $0.61 | 0.0x | 0.2x | — | -105.23% | $2.42M |
| CMNDClearmind Medicine Inc. | $1.76 | — | 0.2x | — | -114.61% | $2.61M |
| OGENOragenics Inc | $0.52 | 0.5x | 0.4x | — | -1307.06% | $2.37M |
| CRISCuris Inc | $0.95 |
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
Company description provided by Yahoo Finance.
| -141.75% |
| -266.00% |
| -1324.81% |
| ROE | -322.85% | -322.85% | -73.58% | -900.14% | — |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| 0.3x |
| 0.4x |
| — |
| — |
| $2.31M |
| RNAZTranscode Therapeutics, Inc. | $2.18 | — | 1.6x | — | -59.28% | $2.31M |
| PPBTPurple Biotech Ltd | $1.68 | — | 0.2x | — | -111.13% | $2.73M |